Loading insider details...
Latest Form 4 (Feb 24, 2026): Grant/Award of 12,050 NGNE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 24, 2026 | Neurogene Inc. (NGNE) | Grant/Award | 12,050 | n/a |
| Oct 30, 2025 | 89bio, Inc. (ETNB) | Grant/Award | 125,000 | n/a |
| Aug 5, 2025 | 89bio, Inc. (ETNB) | Tax Withholding | 55,836 | $511.5K |
| Jun 13, 2025 | Neurogene Inc. (NGNE) | Grant/Award | 12,050 | n/a |
| Feb 19, 2025 | 89bio, Inc. (ETNB) | Tax Withholding | 3,249 | $34.3K |
| Feb 11, 2025 | 89bio, Inc. (ETNB) | Tax Withholding | 8,946 | $102.1K |
| Feb 4, 2025 | 89bio, Inc. (ETNB) | Grant/Award | 212,000 | n/a |
| Dec 10, 2024 | 89bio, Inc. (ETNB) | Purchase | 5,000 | $39.5K |
| Nov 25, 2024 | 89bio, Inc. (ETNB) | Purchase | 10,000 | $83.5K |
| Aug 19, 2024 | 89bio, Inc. (ETNB) | Tax Withholding | 4,601 | $37.0K |